Lactic acid-stabilised albumin for microsphere formulation and biomedical coatings

被引:12
作者
Coombes, AGA
Breeze, V
Wu, LL
Gray, T
Parker, KG
Parker, T
机构
[1] Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England
[2] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Sch Med, Nottingham NG2 7FP, England
[3] Univ Hosp, Queens Med Ctr, Dept Histopathol, Nottingham NG2 7FP, England
关键词
albumin stabilisation; microspheres; coatings; vascular grafts;
D O I
10.1016/S0142-9612(00)00074-0
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Microspheres of ovalbumin (OVA) ranging from 1 to 15 mum were prepared by emulsifying an aqueous solution of albumin in soya oil at room temperature then raising the temperature to 45 degreesC for 30 min, prior to harvesting of the microspheres. Production of OVA nanospheres with size less than 500 nm was achieved by desolvation from aqueous albumin solutions using acetone. In both cases, lactic acid was added to the starting albumin solution to stabilise the resulting particles. Utilisation of an endogenous substance avoids the use of chemical crosslinking agents such as glutaraldehyde and associated toxicological concerns. Protein coating of knitted Dacron vascular grafts was performed by impregnation of the textile structure with lactic acid-stabilised ovalbumin nanospheres thereby providing a surface potentially resistant to blood platelet adhesion but conducive to endothelialisation, Protein release testing carried out in PBS at 37 degreesC revealed that approximately 60% of the original albumin coating was retained by the Dacron graft material after 4 days and remained at this level for upto 4 weeks. Apart from the formulation of albumin microspheres for drug delivery, diagnostic applications and coating of biomedical textiles, the process of albumin stabilisation using lactic acid may be usefully applied to improve protein immobilisation on a wide range of biomaterial surfaces. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 24 条
[1]   STUDY ON THE PREVENTION OF SURFACE-INDUCED PLATELET ACTIVATION BY ALBUMIN COATING [J].
AMIJI, M ;
PARK, H ;
PARK, K .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 1992, 3 (05) :375-388
[2]   ALBUMIN MICROSPHERES AND MICROCAPSULES - METHODOLOGY OF MANUFACTURING TECHNIQUES [J].
ARSHADY, R .
JOURNAL OF CONTROLLED RELEASE, 1990, 14 (02) :111-131
[3]  
BENSLIMANE S, 1988, EUR SURG RES, V20, P18
[4]  
Cappello J., 1997, CONTROLLED DRUG DELI, P439
[5]  
CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
[6]   Single dose, polymeric, microparticle based vaccines: The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen [J].
Coombes, AGA ;
Lavelle, EC ;
Jenkins, PG ;
Davis, SS .
VACCINE, 1996, 14 (15) :1429-1438
[7]  
CZIPERLE DJ, 1992, J CARDIOVASC SURG, V33, P407
[8]   INFLUENCE OF ENDOGENOUS ALBUMIN BINDING ON BLOOD-MATERIAL INTERACTIONS [J].
EBERHART, RC ;
MUNRO, MS ;
FRAUTSCHI, JR ;
LUBIN, M ;
CLUBB, FJ ;
MILLER, CW ;
SEVASTIANOV, VI .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 516 :78-95
[9]   BIODEGRADABLE POLYMERS FOR PROTEIN AND PEPTIDE DRUG-DELIVERY [J].
GOMBOTZ, WR ;
PETTIT, DK .
BIOCONJUGATE CHEMISTRY, 1995, 6 (04) :332-351
[10]   HEALING PARAMETERS OF A NEW ALBUMIN-COATED KNITTED DACRON GRAFT [J].
HAKE, U ;
GABBERT, H ;
IVERSEN, S ;
JAKOB, H ;
SCHMIEDT, W ;
OELERT, H .
THORACIC AND CARDIOVASCULAR SURGEON, 1991, 39 (04) :208-213